Role Of Individualized Homoeopathic Medicines In The Management Of Diabetic Peripheral Neuropathy Using Toronto Clinical Scoring System: A Clinical Study
试验速览
- 阶段
- 不适用
- 状态
- 尚未招募
- 发起方
- 入组人数
- 43
- 试验地点
- 1
- 主要终点
- Role Of Individualized Homoeopathic Medicines In The Management Of Diabetic Peripheral Neuropathy Using Toronto Clinical Scoring System
研究概览
简要总结
The Title Of My Research Is:
"Role Of Individualized Homoeopathic Medicines In The Management Of Diabetic Peripheral Neuropathy Using Toronto Clinical Scoring System: A Clinical Study"
Outline Of The Procedure :
Volunteer Patient Who Are Present With Clinical Features Of Diabetic Peripheral Neuropathy Will Be Recruited From The OPDs Of JNHMCH. The Study Is Designed As A Non-Randomized ,Single-Blind Controlled Trail.
1.Case Taking And Diagnosis:
Case Taking Will Follow The Hahnemannian Schema.
The Diagnosis Will Be Confirmed After RBS, FBS, PP2Bs, HbA1c And Vitamin B12.
2.Number Of Samples:
43 Cases: Patients Will Receive Individualized Homoeopathic Medicines.
3.Assessment And Follow-Up:
The Functional Outcomes Of The Patients Will Be Assessed Using The Toronto Clinical Scoring System.
Follow-Ups Will Be Conducted Every 15 Days, With A Total Of Six Follow-Ups Or As Clinically Required.
A Final Assessment Carried Out After Completing The Follow-Up Period.
Response Will Be Analyzed Into 4 Criteria
Mild Improvement: Toronto Clinical Score Transformed From 8 to 2 Which Indicates Mild Improvement.
Moderate Improvement: Toronto Clinical Score Transformed From 11 To 9 Which Indicates Moderates Improvement .
Significant Improvement: Toronto Clinical Score Transformed From 18 To 12 Which Indicates Significant Improvement.
No Improvement: Toronto Clinical Score Transformed Score 1 Or 0 Which Indicates No Improvement.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 盲法
- Participant Blinded
入排标准
- 年龄范围
- 18.00 Year(s) 至 80.00 Year(s)（—）
- 性别
- All
入选标准
- •Sample Of Both Sexes Aged Above 18 Years Will Be Taken.
- •Newly And Pre Diagnosed Cases Of Diabetic Peripheral neuropathy.
- •Having Clinical Features Such As Numbness In The Feet And Burning Sensation In The Feet Are Included In This Study.
- •Patient Having Consent For The Study.
排除标准
- •Patient Suffering From Others Severe Systemic Diseases Like Chronic Kidney Disease, Coronary Artery Disease, Etc.
- •Advanced And Irreversible Pathological Cases Which Require Immediate Medical Attention.
- •Diabetic Peripheral Neuropathy In Pregnant And Lactating Women.
结局指标
主要结局
Role Of Individualized Homoeopathic Medicines In The Management Of Diabetic Peripheral Neuropathy Using Toronto Clinical Scoring System
时间窗: Follow Up To Be Done After 15 Days, With Minimum 6 Follow Up Or As And When Required
次要结局
- To Check And Verify The Most Common Age Group Affected By Diabetic Peripheral Neuropathy.(To Check Out Most Common Causes Responsible For Diabetic Peripheral Neuropathy)
研究者
Dr Priyanka Rathod
Jawaharlal Nehru Homoeopathic Medical College